GPER1 Mediates Hippocampal Therapeutic Effect of Prunetin in Uremic Encephalopathy: Modulation of the RUNX2 Axis, TLR4 Cascade, Necroptosis, and Mitochondrial Dysfunction
Archiv der Pharmazie · 2025
DOI: 10.1002/ardp.70086 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archiv der Pharmazie, 2025. Verfasst von Ahmed B Hamed und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Toxicology, and Biochemistry, Faculty of Pharmacy, Future University in Egypt, Cairo, Egypt. Hauptthemen laut MEDLINE: Receptors, G-Protein-Coupled, Hippocampus, Receptors, Estrogen, Uremia. Die Arbeit nennt 75 Literaturangaben. Gefördert von: The authors declare that this manuscript was self-funded..
Abstract (Originalsprache)
Renal ischemia/reoxygenation triggers uremic encephalopathy (UE), culminating in cognitive and neural derangements. Despite its neuroprotective functions, the hippocampal repercussion of the estrogen receptor G protein‐coupled estrogen receptor 1 (GPER1) in UE remains uncharted, alongside the prospective involvement of RUNX2. In Silico virtual screening suggested that prunetin (PRU) may activate GPER1 and inhibit RUNX2. To validate these findings in vivo, male Sprague Dawley rats were allocated into five groups: placebo‐surgery (PS), PRU‐treated PS, untreated UE, PRU‐treated UE, and UE pretreated with G‐15 (a selective GPER1 blocker) before PRU. Biochemically, PRU significantly restored hippocampal structure and behavioral functions impaired by UE, reduced serum IS levels, and replenished GPER1 expression. Additionally, it suppressed p‐AKT, p‐GSK3β, RUNX2, TLR4, and NF‐κB, while enhancing cell survival by silencing the necroptotic signal (TICAM1/RIPK1/RIPK3/MLKL) and restoring caspase‐8. PRU also counteracted mitochondrial dysfunction by downregulating PGAM5 and p‐DRP‐1. Crucially, these beneficial effects were nullified by G‐15, confirming the role of activated GPER1 in mediating PRU's therapeutic effects. Collectively, PRU‐induced GPER1 orchestrated neural integrity signal UE/AKT/GSK‐3β/RUNX2, inflammatory axis UE/TLR‐4/NF‐κB, necroptosis pathway (TICAM1/RIPK1/RIPK3/MLKL), preventing mitochondrial dysfunction by suppressing the PGAM5/DRP‐1 cue. These findings highlight the therapeutic potential of PRU in treating UE‐related hippocampal damage through GPER1 activation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, Toxicology, and Biochemistry, Faculty of Pharmacy, Future University in Egypt, Cairo, Egypt.
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Future University in Egypt, Cairo, Egypt.
- Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Cairo, Egypt.
- Department of Pathology, Faculty of Veterinary Medicine, Cairo University, Giza, Egypt.
ORCID-Profile: Ahmed B Hamed, Iten M Fawzy, Dalaal M Abdallah, Hanan S El-Abhar
Förderung
- The authors declare that this manuscript was self-funded.
Zitieren
APA
Hamed, A. B., Fawzy, I. M., Abdallah, D. M., Abulfadl, Y. S., Ahmed, K. A., & El-Abhar, H. S. (2025). GPER1 Mediates Hippocampal Therapeutic Effect of Prunetin in Uremic Encephalopathy: Modulation of the RUNX2 Axis, TLR4 Cascade, Necroptosis, and Mitochondrial Dysfunction. Archiv der Pharmazie. https://doi.org/10.1002/ardp.70086
Vancouver
Hamed AB, Fawzy IM, Abdallah DM, Abulfadl YS, Ahmed KA, El-Abhar HS. GPER1 Mediates Hippocampal Therapeutic Effect of Prunetin in Uremic Encephalopathy: Modulation of the RUNX2 Axis, TLR4 Cascade, Necroptosis, and Mitochondrial Dysfunction. Archiv der Pharmazie. 2025. doi:10.1002/ardp.70086
BibTeX
@article{Hamed2025,
author = {Hamed, Ahmed B and Fawzy, Iten M and Abdallah, Dalaal M and Abulfadl, Yasmin S and Ahmed, Kawkab A and El-Abhar, Hanan S},
title = {GPER1 Mediates Hippocampal Therapeutic Effect of Prunetin in Uremic Encephalopathy: Modulation of the RUNX2 Axis, TLR4 Cascade, Necroptosis, and Mitochondrial Dysfunction},
journal = {Archiv der Pharmazie},
year = {2025},
doi = {10.1002/ardp.70086}
}
EUVIMED